Apply to the 2024 EAZPOD Programme at EMBL-EBI & AstraZeneca in Cambridge. Work on cutting-edge computational biology in oncology with world-class scientists & access to state-of-the-art facilities! Learn more & apply: https://t.co/ji3s10HGbn #Postdoc#Oncology
📢We are recruiting! https://t.co/cuZHHt2lX9 Come join us at @emblebi! Exciting @CR_UK-funded project focused on long-read sequencing data analysis and early cancer detection. Ideal position to train in basic and translational research working w us @adbeggs@generoom & others!
If you’re working in the single cell space definitely check out a new method “SComatic” from @fran_muyas for detecting somatic mutations. Great tweetorials from @isidrolauscher tell you all you need to know! New gold standard for mutation calling.
Very excited to see our study presenting SComatic out in @NatureBiotech! Huge congrats to @fran_muyas and all co-authors!
paper: https://t.co/IpgP7VusVD
briefing: https://t.co/VUnLDg2sej
news: https://t.co/o7I5tB6MjO thread👇
By leveraging @nanopore sequencing, postdoctoral researcher @Carolinmsa and colleagues are developing new methods for early cancer detection.
Find out how combining these new technologies with liquid biopsies is helping to create less invasive procedures.
https://t.co/T4vbd7w9es
Very pleased to see the preprint of my main PhD project out on @bioRxiv! Big thank you to all collaborators and the fantastically clever centrosome and cancer genomics people who have shared their knowledge & advice with me over the last 4 years! @CRUK_CI
https://t.co/Q6KHaOs86r
🚨 New job alert 🚨
We are looking for a nice and dedicated #ResearchAssistant to join us and help us with our expanding 🐭colonies, organoids 🧫 and #PancreaticCancerResearch.
2-year commitment in the first instance.
Please RT. ❤️
To apply 👇🏼👇🏼
https://t.co/XmT5G8bnHr
I'm happy to share my latest research interpreting the genetics of cardiovascular disease using transcriptomic network modeling. Based on multitissue human RNA-seq samples, we identified adipose endocrines affecting liver-mediated metabolic dysfunction.
https://t.co/BgcYPmSmey
I'm very excited to share this story @genomeresearch from my postdoc at the @steinaerts lab! With @ibrahimihsan, we investigated cis-regulatory variants in melanoma using phased whole genomes and a new melanoma-specific deep learning model. https://t.co/IBka5sqDen
📸 Thank you to PhD student Anne Machel (@MillerLab4) for capturing this video of the beautiful snow outside of the Institute on the @CamBioCampus this weekend ❄️⛄️
@CRUKresearch@CR_UK
Dr Sarah Halford (@sarahhalford7), Head of Medical Sciences at the Cancer Research UK Centre for Drug Development spoke to @EPM_Magazine about the setup of the Spike 1 clinical trial and its COVID-19 efforts.
Read the article: https://t.co/2lkKpi34kN
Our group is looking for an immunologist postdoc. Come & join us! Details here: https://t.co/5OjpeypEsM
(Cartoon courtesy of https://t.co/398v1xYI3r…)
Our @MillerLab4 has a PhD project available titled "Interrogating tumour-associated mechanisms of immune escape in #PancreaticCancer".
Find out more 👉 https://t.co/qYYgvZwlKy
On a related, but much happier note, I present to you the true #breadwinners of the #BiffiLab: @JAraosHenriquez and @eloise_g_lloyd, which both got their own scholarships to start their PhD today! #ProudPI
And thanks to @The_MRC and @Cambridge_Trust for supporting their studies!
Our work on clonal evolution in melanoma is out @NatureComms! Genome-wide analyses of multiple metastases sampled at autopsy followed by multisite analyses from a patient series allowed us to take a deeper look into heterogeneity.[1/8] https://t.co/3DRF0Nx9IP